Correlation Between Red Branch and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Red Branch and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Red Branch and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Red Branch Technologies and Mink Therapeutics, you can compare the effects of market volatilities on Red Branch and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Red Branch with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Red Branch and Mink Therapeutics.
Diversification Opportunities for Red Branch and Mink Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Red and Mink is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Red Branch Technologies and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Red Branch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Red Branch Technologies are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Red Branch i.e., Red Branch and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Red Branch and Mink Therapeutics
If you would invest 786.00 in Mink Therapeutics on December 4, 2024 and sell it today you would earn a total of 109.00 from holding Mink Therapeutics or generate 13.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Red Branch Technologies vs. Mink Therapeutics
Performance |
Timeline |
Red Branch Technologies |
Mink Therapeutics |
Red Branch and Mink Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Red Branch and Mink Therapeutics
The main advantage of trading using opposite Red Branch and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Red Branch position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.Red Branch vs. HeartCore Enterprises | Red Branch vs. Trust Stamp | Red Branch vs. Quhuo | Red Branch vs. C3 Ai Inc |
Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |